The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. [electronic resource]
Producer: 20170509Description: 37-48 p. digitalISSN:- 1090-2430
- Animals
- Antineoplastic Agents -- toxicity
- Brain -- drug effects
- Calcium-Binding Proteins -- metabolism
- Conotoxins -- therapeutic use
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Ganglia, Spinal -- pathology
- Glial Fibrillary Acidic Protein -- metabolism
- Hyperalgesia -- drug therapy
- Male
- Microfilament Proteins -- metabolism
- Neuralgia -- chemically induced
- Neuroglia -- drug effects
- Nicotinic Antagonists -- therapeutic use
- Organoplatinum Compounds -- toxicity
- Oxaliplatin
- Pain Measurement
- Pain Threshold -- drug effects
- Rats
- Rats, Sprague-Dawley
- Reaction Time -- drug effects
- Spinal Cord -- metabolism
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.